Free Trial
BTIG Research

BTIG Research Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at BTIG Research. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from BTIG Research's equity research team. MarketBeat is not affiliated with or endorsed by BTIG Research.

Average Return
00.00% 12-Month ROI
Total Ratings
2,085 Last 12 Months
Buy Ratings
1,859 Last 12 Months
Sell Ratings
18 Last 12 Months
Companies Covered
536 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
0 Results
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Carvana Co. stock logo
CVNA
Carvana
$63.72
0.0%
10/9/2026Reiterated Rating$87.00BuyView details for BTIG Research rating of Carvana (NYSE:CVNA) on 10/9/2026
Liftoff Mobile, Inc. stock logo
LFTO
Liftoff Mobile
$15.41
10/9/2026Lower Price Target$35.00 ➝ $27.00BuyView details for BTIG Research rating of Liftoff Mobile (NASDAQ:LFTO) on 10/9/2026
Nektar Therapeutics stock logo
NKTR
Nektar Therapeutics
$41.17
10/9/2026Reiterated Rating$178.00BuyView details for BTIG Research rating of Nektar Therapeutics (NASDAQ:NKTR) on 10/9/2026
Tidewater Inc. stock logo
TDW
Tidewater
$85.15
-0.3%
10/9/2026Reiterated Rating$120.00BuyView details for BTIG Research rating of Tidewater (NYSE:TDW) on 10/9/2026
Unity Software Inc. stock logo
U
Unity Software
$46.95
+0.1%
10/9/2026Boost Price Target$51.00 ➝ $53.00BuyView details for BTIG Research rating of Unity Software (NYSE:U) on 10/9/2026
Starbucks Corporation stock logo
SBUX
Starbucks
$90.75
10/8/2026Reiterated RatingBuyView details for BTIG Research rating of Starbucks (NASDAQ:SBUX) on 10/8/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
$118.86
+0.1%
10/8/2026Boost Price Target$110.00 ➝ $130.00BuyView details for BTIG Research rating of Haemonetics (NYSE:HAE) on 10/8/2026
Levi Strauss & Co. stock logo
LEVI
Levi Strauss & Co.
$18.71
+0.0%
10/8/2026Reiterated Rating$27.00BuyView details for BTIG Research rating of Levi Strauss & Co. (NYSE:LEVI) on 10/8/2026
Nomad Foods Limited stock logo
NOMD
Nomad Foods
$11.07
-0.1%
10/8/2026Reiterated Rating$15.00BuyView details for BTIG Research rating of Nomad Foods (NYSE:NOMD) on 10/8/2026
Ispire Technology Inc. stock logo
ISPR
Ispire Technology
$1.52
10/7/2026Set Price Target$3.30View details for BTIG Research rating of Ispire Technology (NASDAQ:ISPR) on 10/7/2026
ArriVent BioPharma, Inc. stock logo
AVBP
ArriVent BioPharma
$16.73
10/7/2026Lower Price Target$42.00 ➝ $29.00BuyView details for BTIG Research rating of ArriVent BioPharma (NASDAQ:AVBP) on 10/7/2026
Abercrombie & Fitch Company stock logo
ANF
Abercrombie & Fitch
$142.71
+0.1%
10/7/2026Reiterated Rating$175.00BuyView details for BTIG Research rating of Abercrombie & Fitch (NYSE:ANF) on 10/7/2026
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
$2.66
10/7/2026Reiterated Rating$14.00BuyView details for BTIG Research rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 10/7/2026
Coinbase Global, Inc. stock logo
COIN
Coinbase Global
$179.39
10/7/2026Reiterated Rating$240.00BuyView details for BTIG Research rating of Coinbase Global (NASDAQ:COIN) on 10/7/2026
Harrow, Inc. stock logo
HROW
Harrow
$29.36
10/7/2026Reiterated Rating$63.00BuyView details for BTIG Research rating of Harrow (NASDAQ:HROW) on 10/7/2026
Neostellar Capital stock logo
NSLR
Neostellar Capital
$7.27
10/7/2026Lower Price Target$15.00 ➝ $14.00BuyView details for BTIG Research rating of Neostellar Capital (NASDAQ:NSLR) on 10/7/2026
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$18.50
10/7/2026Reiterated RatingNeutralView details for BTIG Research rating of Simulations Plus (NASDAQ:SLP) on 10/7/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$233.73
10/7/2026Reiterated RatingNeutralView details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 10/7/2026
Velocity Financial, Inc. stock logo
VEL
Velocity Financial
$14.77
+0.3%
10/6/2026Lower Price Target$22.00 ➝ $20.00BuyView details for BTIG Research rating of Velocity Financial (NYSE:VEL) on 10/6/2026
Redwood Trust, Inc. stock logo
RWT
Redwood Trust
$3.19
+0.5%
10/6/2026Lower Price Target$6.00 ➝ $5.00BuyView details for BTIG Research rating of Redwood Trust (NYSE:RWT) on 10/6/2026
MFA Financial, Inc. stock logo
MFA
MFA Financial
$6.90
+0.2%
10/6/2026Reiterated Rating$10.50 ➝ $9.50BuyView details for BTIG Research rating of MFA Financial (NYSE:MFA) on 10/6/2026
Dynex Capital, Inc. stock logo
DX
Dynex Capital
$10.85
-0.1%
10/6/2026Set Price Target$14.50 ➝ $12.00BuyView details for BTIG Research rating of Dynex Capital (NYSE:DX) on 10/6/2026
Annaly Capital Management Inc stock logo
NLY
Annaly Capital Management
$18.33
+0.1%
10/6/2026Set Price Target$24.00 ➝ $21.00BuyView details for BTIG Research rating of Annaly Capital Management (NYSE:NLY) on 10/6/2026
Angel Oak Mortgage REIT Inc. stock logo
AOMR
Angel Oak Mortgage REIT
$7.24
-0.3%
10/6/2026Lower Price Target$10.00 ➝ $9.00BuyView details for BTIG Research rating of Angel Oak Mortgage REIT (NYSE:AOMR) on 10/6/2026
Uber Technologies, Inc. stock logo
UBER
Uber Technologies
$71.47
-0.1%
10/6/2026Reiterated Rating$100.00BuyView details for BTIG Research rating of Uber Technologies (NYSE:UBER) on 10/6/2026
Personalis, Inc. stock logo
PSNL
Personalis
$16.00
10/6/2026DowngradeBuy ➝ NeutralView details for BTIG Research rating of Personalis (NASDAQ:PSNL) on 10/6/2026
Sphere Entertainment Co. stock logo
SPHR
Sphere Entertainment
$106.64
+0.2%
10/6/2026Lower Price Target$190.00 ➝ $160.00BuyView details for BTIG Research rating of Sphere Entertainment (NYSE:SPHR) on 10/6/2026
Expedia Group, Inc. stock logo
EXPE
Expedia Group
$274.22
10/6/2026Reiterated Rating$400.00BuyView details for BTIG Research rating of Expedia Group (NASDAQ:EXPE) on 10/6/2026
Cloudflare, Inc. stock logo
NET
Cloudflare
$360.32
-0.2%
10/6/2026Boost Price Target$382.00 ➝ $413.00BuyView details for BTIG Research rating of Cloudflare (NYSE:NET) on 10/6/2026
Netskope Inc. stock logo
NTSK
Netskope
$20.75
0.0%
10/6/2026Boost Price Target$18.00 ➝ $22.00BuyView details for BTIG Research rating of Netskope (NASDAQ:NTSK) on 10/6/2026
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
$259.86
10/6/2026Boost Price Target$810.00 ➝ $826.00BuyView details for BTIG Research rating of Praxis Precision Medicines (NASDAQ:PRAX) on 10/6/2026
Gain Therapeutics, Inc. stock logo
GANX
Gain Therapeutics
$1.64
10/5/2026Reiterated Rating$5.00BuyView details for BTIG Research rating of Gain Therapeutics (NASDAQ:GANX) on 10/5/2026
Oxford Industries, Inc. stock logo
OXM
Oxford Industries
$25.38
10/5/2026Reiterated RatingNeutralView details for BTIG Research rating of Oxford Industries (NYSE:OXM) on 10/5/2026
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
$71.38
10/5/2026Reiterated Rating$89.00BuyView details for BTIG Research rating of Vaxcyte (NASDAQ:PCVX) on 10/5/2026
Verastem, Inc. stock logo
VSTM
Verastem
$8.38
10/5/2026Reiterated Rating$18.00BuyView details for BTIG Research rating of Verastem (NASDAQ:VSTM) on 10/5/2026
NIKE, Inc. stock logo
NKE
NIKE
$34.74
+0.1%
10/2/2026Lower Price Target$55.00 ➝ $50.00BuyView details for BTIG Research rating of NIKE (NYSE:NKE) on 10/2/2026
ServiceTitan Inc. stock logo
TTAN
ServiceTitan
$72.59
10/2/2026Reiterated Rating$110.00BuyView details for BTIG Research rating of ServiceTitan (NASDAQ:TTAN) on 10/2/2026
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
$2.00
10/1/2026DowngradeBuy ➝ NeutralView details for BTIG Research rating of Foghorn Therapeutics (NASDAQ:FHTX) on 10/1/2026
BP p.l.c. stock logo
BP
BP
$46.22
-0.1%
10/1/2026 DowngradeNeutralView details for BTIG Research rating of BP (NYSE:BP) on 10/1/2026
Liquidia Corporation stock logo
LQDA
Liquidia
$27.38
10/1/2026DowngradeBuy ➝ NeutralView details for BTIG Research rating of Liquidia (NASDAQ:LQDA) on 10/1/2026
Urgent Attention to Executive Order #14363 (Buy This Stock Before Oct. 20th (Ad)

Marc Chaikin, a 60-year Wall Street veteran whose past clients include George Soros and Steve Cohen, built a system that flagged Nvidia before it climbed more than 50,000%. Following Executive Order #14363, next-generation AI data centers are coming online, and Chaikin says one stock is leading this buildout.tc pixel

Get the stock name and ticker from Chaikin's research now.
Braze, Inc. stock logo
BRZE
Braze
$29.06
10/1/2026Reiterated Rating$35.00BuyView details for BTIG Research rating of Braze (NASDAQ:BRZE) on 10/1/2026
DraftKings Inc. stock logo
DKNG
DraftKings
$19.58
10/1/2026Lower Price Target$30.00 ➝ $25.00BuyView details for BTIG Research rating of DraftKings (NASDAQ:DKNG) on 10/1/2026
Flutter Entertainment PLC stock logo
FLUT
Flutter Entertainment
$79.76
0.0%
10/1/2026Lower Price Target$113.00 ➝ $110.00BuyView details for BTIG Research rating of Flutter Entertainment (NYSE:FLUT) on 10/1/2026
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
$85.69
10/1/2026Reiterated Rating$121.00BuyView details for BTIG Research rating of Spyre Therapeutics (NASDAQ:SYRE) on 10/1/2026
BWX Technologies, Inc. stock logo
BWXT
BWX Technologies
$143.73
-0.1%
9/30/2026Reiterated Rating$235.00BuyView details for BTIG Research rating of BWX Technologies (NYSE:BWXT) on 9/30/2026
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
$0.87
9/30/2026Lower Price Target$5.00BuyView details for BTIG Research rating of Connect Biopharma (NASDAQ:CNTB) on 9/30/2026
Global Business Travel Group, Inc. stock logo
GBTG
Global Business Travel Group
$9.50
9/30/2026Reiterated RatingNeutralView details for BTIG Research rating of Global Business Travel Group (NYSE:GBTG) on 9/30/2026
Levi Strauss & Co. stock logo
LEVI
Levi Strauss & Co.
$18.71
+0.0%
9/30/2026Reiterated Rating$27.00BuyView details for BTIG Research rating of Levi Strauss & Co. (NYSE:LEVI) on 9/30/2026
Aldeyra Therapeutics, Inc. stock logo
ALDX
Aldeyra Therapeutics
$0.92
9/29/2026Reiterated RatingBuyView details for BTIG Research rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 9/29/2026
Robinhood Markets, Inc. stock logo
HOOD
Robinhood Markets
$109.02
9/29/2026Boost Price Target$125.00 ➝ $135.00BuyView details for BTIG Research rating of Robinhood Markets (NASDAQ:HOOD) on 9/29/2026
Sphere Entertainment Co. stock logo
SPHR
Sphere Entertainment
$106.64
+0.2%
9/28/2026Reiterated RatingBuyView details for BTIG Research rating of Sphere Entertainment (NYSE:SPHR) on 9/28/2026
Carlsmed, Inc. stock logo
CARL
Carlsmed
$14.42
9/28/2026Reiterated Rating$23.00BuyView details for BTIG Research rating of Carlsmed (NASDAQ:CARL) on 9/28/2026
FTAI Infrastructure Inc. stock logo
FIP
FTAI Infrastructure
$2.65
9/28/2026Reiterated Rating$9.00BuyView details for BTIG Research rating of FTAI Infrastructure (NASDAQ:FIP) on 9/28/2026
Palo Alto Networks, Inc. stock logo
PANW
Palo Alto Networks
$418.78
9/28/2026Boost Price Target$404.00 ➝ $425.00BuyView details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 9/28/2026
Infleqtion stock logo
INFQ
Infleqtion
$11.05
+0.0%
9/25/2026 Reiterated Rating$25.00BuyView details for BTIG Research rating of Infleqtion (NYSE:INFQ) on 9/25/2026
Consensus Cloud Solutions, Inc. stock logo
CCSI
Consensus Cloud Solutions
$36.71
9/25/2026Reiterated Rating$50.00BuyView details for BTIG Research rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 9/25/2026
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
$15.53
9/25/2026Reiterated Rating$40.00BuyView details for BTIG Research rating of Cullinan Therapeutics (NASDAQ:CGEM) on 9/25/2026
Darden Restaurants, Inc. stock logo
DRI
Darden Restaurants
$197.44
-0.1%
9/25/2026Reiterated Rating$235.00BuyView details for BTIG Research rating of Darden Restaurants (NYSE:DRI) on 9/25/2026
Nektar Therapeutics stock logo
NKTR
Nektar Therapeutics
$41.17
9/25/2026Reiterated Rating$178.00BuyView details for BTIG Research rating of Nektar Therapeutics (NASDAQ:NKTR) on 9/25/2026
Block, Inc. stock logo
XYZ
Block
$77.34
+0.1%
9/25/2026Reiterated Rating$100.00BuyView details for BTIG Research rating of Block (NYSE:XYZ) on 9/25/2026
CareDx, Inc. stock logo
CDNA
CareDx
$63.67
9/24/2026Boost Price Target$60.00 ➝ $74.00BuyView details for BTIG Research rating of CareDx (NASDAQ:CDNA) on 9/24/2026
Golar LNG Limited stock logo
GLNG
Golar LNG
$47.92
9/24/2026Boost Price Target$70.00 ➝ $75.00BuyView details for BTIG Research rating of Golar LNG (NASDAQ:GLNG) on 9/24/2026
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
$13.74
9/24/2026Lower Price Target$23.00 ➝ $20.00BuyView details for BTIG Research rating of Arcturus Therapeutics (NASDAQ:ARCT) on 9/24/2026
Booking Holdings Inc. stock logo
BKNG
Booking
$160.34
9/24/2026Reiterated Rating$250.00BuyView details for BTIG Research rating of Booking (NASDAQ:BKNG) on 9/24/2026
McDonald's Corporation stock logo
MCD
McDonald's
$235.42
+0.1%
9/24/2026Lower Price Target$350.00 ➝ $295.00BuyView details for BTIG Research rating of McDonald’s (NYSE:MCD) on 9/24/2026
Okta, Inc. stock logo
OKTA
Okta
$232.13
9/24/2026Reiterated Rating$219.00BuyView details for BTIG Research rating of Okta (NASDAQ:OKTA) on 9/24/2026
Theravance Biopharma, Inc. stock logo
TBPH
Theravance Biopharma
$17.03
9/24/2026Reiterated RatingNeutralView details for BTIG Research rating of Theravance Biopharma (NASDAQ:TBPH) on 9/24/2026
Tyler Technologies, Inc. stock logo
TYL
Tyler Technologies
$329.45
0.0%
9/24/2026Reiterated Rating$400.00BuyView details for BTIG Research rating of Tyler Technologies (NYSE:TYL) on 9/24/2026
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$53.81
9/23/2026Initiated Coverage$70.00BuyView details for BTIG Research rating of Pulse Biosciences (NASDAQ:PLSE) on 9/23/2026
On Holding AG stock logo
ONON
ON
$35.05
-0.1%
9/23/2026Reiterated Rating$60.00BuyView details for BTIG Research rating of ON (NYSE:ONON) on 9/23/2026
AC Immune stock logo
ACIU
AC Immune
$2.50
9/23/2026Reiterated Rating$8.00BuyView details for BTIG Research rating of AC Immune (NASDAQ:ACIU) on 9/23/2026
Costco Wholesale Corporation stock logo
COST
Costco Wholesale
$946.92
9/23/2026Reiterated Rating$1,125.00BuyView details for BTIG Research rating of Costco Wholesale (NASDAQ:COST) on 9/23/2026
NIKE, Inc. stock logo
NKE
NIKE
$34.74
+0.1%
9/23/2026Reiterated Rating$55.00BuyView details for BTIG Research rating of NIKE (NYSE:NKE) on 9/23/2026
Oric Pharmaceuticals, Inc. stock logo
ORIC
Oric Pharmaceuticals
$11.99
9/23/2026Initiated Coverage$26.00BuyView details for BTIG Research rating of Oric Pharmaceuticals (NASDAQ:ORIC) on 9/23/2026
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$53.81
9/23/2026Initiated Coverage$70.00BuyView details for BTIG Research rating of Pulse Biosciences (NASDAQ:PLSE) on 9/23/2026
NVR, Inc. stock logo
NVR
NVR
$5,900.33
+0.0%
9/22/2026Set Price Target$7,125.00View details for BTIG Research rating of NVR (NYSE:NVR) on 9/22/2026
D.R. Horton, Inc. stock logo
DHI
D.R. Horton
$134.91
+0.0%
9/22/2026Reiterated Rating$174.00BuyView details for BTIG Research rating of D.R. Horton (NYSE:DHI) on 9/22/2026
Enact Holdings, Inc. stock logo
ACT
Enact
$45.97
9/22/2026 Initiated CoverageNeutralView details for BTIG Research rating of Enact (NASDAQ:ACT) on 9/22/2026
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
$26.49
9/22/2026Boost Price Target$25.00 ➝ $34.00BuyView details for BTIG Research rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 9/22/2026
Atlanticus Holdings Corporation stock logo
ATLC
Atlanticus
$93.73
9/22/2026Reiterated Rating$179.00BuyView details for BTIG Research rating of Atlanticus (NASDAQ:ATLC) on 9/22/2026
Essent Group Ltd. stock logo
ESNT
Essent Group
$62.48
0.0%
9/22/2026 Initiated CoverageHoldView details for BTIG Research rating of Essent Group (NYSE:ESNT) on 9/22/2026
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$0.93
9/22/2026Reiterated Rating$2.00BuyView details for BTIG Research rating of Hyperfine (NASDAQ:HYPR) on 9/22/2026
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
$27.11
9/22/2026Reiterated Rating$46.00BuyView details for BTIG Research rating of Maze Therapeutics (NASDAQ:MAZE) on 9/22/2026
McGraw Hill, Inc. stock logo
MH
McGraw Hill
$13.36
0.0%
9/22/2026Reiterated Rating$17.00BuyView details for BTIG Research rating of McGraw Hill (NYSE:MH) on 9/22/2026
MGIC Investment Corporation stock logo
MTG
MGIC Investment
$27.42
0.0%
9/22/2026 Initiated CoverageHoldView details for BTIG Research rating of MGIC Investment (NYSE:MTG) on 9/22/2026
NMI Holdings Inc stock logo
NMIH
NMI
$40.01
9/22/2026 Initiated Coverage$54.00BuyView details for BTIG Research rating of NMI (NASDAQ:NMIH) on 9/22/2026
Radian Group Inc. stock logo
RDN
Radian Group
$33.95
+0.1%
9/22/2026 Initiated Coverage$48.00BuyView details for BTIG Research rating of Radian Group (NYSE:RDN) on 9/22/2026
Tiziana Life Sciences Ltd stock logo
TLSA
Tiziana Life Sciences
$1.19
9/22/2026Reiterated RatingBuyView details for BTIG Research rating of Tiziana Life Sciences (NASDAQ:TLSA) on 9/22/2026
Upstart Holdings, Inc. stock logo
UPST
Upstart
$24.10
9/22/2026Reiterated Rating$43.00BuyView details for BTIG Research rating of Upstart (NASDAQ:UPST) on 9/22/2026
Spire Inc. stock logo
SR
Spire
$78.41
0.0%
9/21/2026Reiterated Rating$102.00BuyView details for BTIG Research rating of Spire (NYSE:SR) on 9/21/2026
My public warning after 55 years of watching the markets (Ad)

Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel

See Martin Weiss's full warning before this risk spreads further
Invitation Home stock logo
INVH
Invitation Home
$26.77
-0.1%
9/21/2026 Set Price Target$32.00View details for BTIG Research rating of Invitation Home (NYSE:INVH) on 9/21/2026
IQM Quantum Computers stock logo
IQMX
IQM Quantum Computers
$10.23
9/21/2026Initiated Coverage$20.00BuyView details for BTIG Research rating of IQM Quantum Computers (NASDAQ:IQMX) on 9/21/2026
IQM Quantum Computers stock logo
IQMX
IQM Quantum Computers
$10.23
9/21/2026Initiated Coverage$20.00BuyView details for BTIG Research rating of IQM Quantum Computers (NASDAQ:IQMX) on 9/21/2026
Lyft, Inc. stock logo
LYFT
Lyft
$16.22
9/18/2026 Reiterated RatingNeutralView details for BTIG Research rating of Lyft (NASDAQ:LYFT) on 9/18/2026
Lennar Corporation stock logo
LEN
Lennar
$76.54
-0.2%
9/18/2026Reiterated Rating$63.00SellView details for BTIG Research rating of Lennar (NYSE:LEN) on 9/18/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
$74.69
+0.1%
9/18/2026 Reiterated RatingNeutralView details for BTIG Research rating of Globus Medical (NYSE:GMED) on 9/18/2026
Autodesk, Inc. stock logo
ADSK
Autodesk
$235.35
9/18/2026Reiterated Rating$300.00BuyView details for BTIG Research rating of Autodesk (NASDAQ:ADSK) on 9/18/2026
Amer Sports, Inc. stock logo
AS
Amer Sports
$28.13
0.0%
9/18/2026Reiterated Rating$42.00BuyView details for BTIG Research rating of Amer Sports (NYSE:AS) on 9/18/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
$17.35
9/18/2026Reiterated Rating$25.00BuyView details for BTIG Research rating of CryoPort (NASDAQ:CYRX) on 9/18/2026
DHT Holdings, Inc. stock logo
DHT
DHT
$24.65
+0.0%
9/18/2026Boost Price Target$23.00 ➝ $28.00BuyView details for BTIG Research rating of DHT (NYSE:DHT) on 9/18/2026

MarketBeat's community ratings are surveys of what our community members think about BTIG Research and other research firms in the last 90 days. Vote "Outperform" if you believe BTIG Research's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe BTIG Research's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES
0 Believe will outperform the market
UNDERPERFORM VOTES
0 Believe will underperform the market

BTIG Research's equity research team has issued ratings on 531 companies across 11 sectors over the past 12 months, covered by 38 analysts. The BTIG Research analysts below are listed by number of ratings issued in the last year.

BTIG Research Stock Coverage by Sector

BTIG Research concentrates its research most heavily in Healthcare (32.8%), Technology (14.2%) and Consumer Discretionary (14.2%). The chart below shows how BTIG Research's 536 rated companies are distributed across all 11 sectors it covers.

BTIG Research - Frequently Asked Questions

BTIG Research's analysts currently have buy-equivalent ratings on 431 companies. Recent upgrades to buy include Etsy, Tidewater, Alpha Teknova, Avita Medical and Oncobiologics.

BTIG Research's highest-rated analysts by MarketBeat's accuracy score include Jeet Mukherjee, Gregory Lewis and Thomas Shrader. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 43 analysts at BTIG Research.

BTIG Research has the deepest coverage in Healthcare (32.8% of rated companies), Consumer Discretionary (14.2% of rated companies), Technology (14.2% of rated companies), Finance (11.8% of rated companies) and Industrials (6.0% of rated companies).

BTIG Research issued 2,085 ratings over the last 12 months across 536 companies — an average of roughly 174 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current BTIG Research analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. BTIG Research uses Buy, Neutral, and Sell as their equivalents.